Source: DGNews | Posted 8 years ago
FDA Grants Marketing Approval for Benicar HCT (Olmesartan Medoxomil-Hydrochlorothiazide) Treatment For Hypertension
Tags:
PARSIPPANY, NJ -- June 9, 2003 -- Sankyo Pharma Inc. announced today the marketing approval of Benicar HCT by the U.S. Food and Drug Administration (FDA) for second-line treatment of hypertension. Benicar HCT combines the angiotensin II receptor blocker (ARB) Benicar
Comments